Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?
Paul BreillatAlexis MathianFlore RozenbergAmélie DutheilAnnick BarbaudZahir AmouraFrançois ChassetPublished in: Lupus (2023)
Keyphrases